首页> 外文期刊>The American Journal of Human Genetics >Recessive and dominant mutations in retinoic acid receptor beta in cases with microphthalmia and diaphragmatic hernia
【24h】

Recessive and dominant mutations in retinoic acid receptor beta in cases with microphthalmia and diaphragmatic hernia

机译:小眼和and肌疝患者视黄酸受体β的隐性和显性突变

获取原文
获取原文并翻译 | 示例
           

摘要

Anophthalmia and/or microphthalmia, pulmonary hypoplasia, diaphragmatic hernia, and cardiac defects are the main features of PDAC syndrome. Recessive mutations in STRA6, encoding a membrane receptor for the retinol-binding protein, have been identified in some cases with PDAC syndrome, although many cases have remained unexplained. Using whole-exome sequencing, we found that two PDAC-syndrome-affected siblings, but not their unaffected sibling, were compound heterozygous for nonsense (c.355C>T [p.Arg119*]) and frameshift (c.1201-1202insCT [p.Ile403Serfs*15]) mutations in retinoic acid receptor beta (RARB). Transfection studies showed that p.Arg119* and p.Ile403Serfs*15 altered RARB had no transcriptional activity in response to ligands, confirming that the mutations induced a loss of function. We then sequenced RARB in 15 subjects with anophthalmia and/or microphthalmia and at least one other feature of PDAC syndrome. Surprisingly, three unrelated subjects with microphthalmia and diaphragmatic hernia showed de novo missense mutations affecting the same codon; two of the subjects had the c.1159C>T (Arg387Cys) mutation, whereas the other one carried the c.1159C>A (p.Arg387Ser) mutation. We found that compared to the wild-type receptor, p.Arg387Ser and p.Arg387Cys altered RARB induced a 2- to 3-fold increase in transcriptional activity in response to retinoic acid ligands, suggesting a gain-of-function mechanism. Our study thus suggests that both recessive and dominant mutations in RARB cause anophthalmia and/or microphthalmia and diaphragmatic hernia, providing further evidence of the crucial role of the retinoic acid pathway during eye development and organogenesis.
机译:失眼症和/或小眼症,肺发育不全,diaphragm肌疝和心脏缺陷是PDAC综合征的主要特征。在一些患有PDAC综合征的病例中,已经确定了编码视黄醇结合蛋白膜受体的STRA6的隐性突变,尽管仍有许多病例无法解释。使用全外显子测序,我们发现两个受PDAC综合征影响的同胞,而不是其未受影响的同胞,是无意义的复合杂合子(c.355C> T [p.Arg119 *])和移码(c.1201-1202insCT [c.1201-1202insCT] p.Ile403Serfs * 15])在视黄酸受体β(RARB)中发生突变。转染研究表明,p.Arg119 *和p.Ile403Serfs * 15改变的RARB没有响应配体的转录活性,证实了该突变引起功能丧失。然后,我们对15名患有失眼症和/或小眼症以及PDAC综合征至少一个特征的受试者进行了RARB测序。令人惊讶的是,三名无关的小眼症和m肌疝患者显示了从头错义突变,影响了同一密码子。其中两名受试者出现了c.1159C> T(Arg387Cys)突变,而另一名受试者出现了c.1159C> A(p.Arg387Ser)突变。我们发现,与野生型受体相比,p.Arg387Ser和p.Arg387Cys改变的RARB响应视黄酸配体而诱导了2到3倍的转录活性增加,表明功能增强机制。因此,我们的研究表明,RARB的隐性和显性突变均会引起失眼症和/或小眼症和diaphragm肌疝,为视黄酸途径在眼睛发育和器官发生中的关键作用提供了进一步的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号